Literature DB >> 29672815

Minimally Invasive, Isolated Tricuspid Valve Redo Surgery: A Safety and Outcome Analysis.

Gloria Färber1, Sophie Tkebuchava1, Rodolfo Siordia Dawson1, Hristo Kirov1, Mahmoud Diab1, Peter Schlattmann2, Torsten Doenst1.   

Abstract

BACKGROUND: Isolated tricuspid valve (TV) surgery is considered a high risk-procedure. The optimal surgical approach is controversial. We analyzed our experience with isolated TV redo surgery performed either minimally invasively (redo-MITS) or through sternotomy.
METHODS: We retrospectively analyzed all patients with previous cardiac surgery who underwent redo-MITS (n = 26) and compared them to redo-Sternotomy (n = 17). A group of primary-MITS (n = 61) served as control.
RESULTS: The redo-MITS approach consisted of a right anterolateral mini-thoracotomy, transpericardial right atrial access, and beating heart TV surgery without caval occlusion. Redo-MITS patients were oldest and had the most comorbidities (EuroScore II: 9.83 ± 6.05% versus redo-Sternotomy: 8.42 ± 7.33% versus primary-MITS: 4.15 ± 4.84%). There were no intraoperative complications or conversions to sternotomy in both MITS groups. Redo-Sternotomy had the highest 30-day mortality (24%), the poorest long-term survival, and the highest perioperative complication rate. Redo-MITS did not differ in perioperative outcome from primary-MITS. Multivariable logistic regression analysis identified redo-Sternotomy (odds ratio [OR] = 9.76; 95% confidence interval [CI] 1.88-63.26), liver cirrhosis (OR = 9.88; 95% CI 2.20-54.20), and body mass index (BMI) (OR = 1.16; 95% CI 1.02-1.35) as independent predictors of 30-day mortality. The Cox model revealed redo-Sternotomy (hazard ratio [HR] = 2.67; 95% CI 1.18-6.03), liver cirrhosis (HR = 3.31; 95% CI 1.45-7.58), and pulmonary hypertension (HR = 2.26; 95% CI 1.04-4.92) as risk factors for poor long-term survival. TV surgery significantly reduces NYHA class.
CONCLUSION: Minimally invasive, isolated TV surgery as reoperation without caval occlusion and on the beating heart can be safe and may improve clinical outcome. Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2018        PMID: 29672815     DOI: 10.1055/s-0038-1627452

Source DB:  PubMed          Journal:  Thorac Cardiovasc Surg        ISSN: 0171-6425            Impact factor:   1.827


  5 in total

Review 1.  Cardiac surgery 2018 reviewed.

Authors:  Torsten Doenst; Steffen Bargenda; Hristo Kirov; Alexandros Moschovas; Sophie Tkebuchava; Rauf Safarov; Mahmoud Diab; Gloria Faerber
Journal:  Clin Res Cardiol       Date:  2019-03-30       Impact factor: 5.460

2.  Hemodynamic Characteristics and Outcomes of Pulmonary Hypertension in Patients Undergoing Tricuspid Valve Repair or Replacement.

Authors:  Mahima Vijayaraghavan; Kurt W Prins; Sasha Z Prisco; Sue Duval; Ranjit John; Stephen L Archer; E Kenneth Weir; Rochus Voeller; Andrew W Shaffer; Thenappan Thenappan
Journal:  CJC Open       Date:  2020-12-16

Review 3.  Minimally invasive tricuspid valve surgery.

Authors:  Abdelrahman Abdelbar; Ayman Kenawy; Joseph Zacharias
Journal:  J Thorac Dis       Date:  2021-03       Impact factor: 2.895

4.  Determinants of Morbidity and Mortality Associated With Isolated Tricuspid Valve Surgery.

Authors:  Akram Kawsara; Fahad Alqahtani; Vuyisile T Nkomo; Mackram F Eleid; Sorin V Pislaru; Charanjit S Rihal; Rick A Nishimura; Hartzell V Schaff; Juan A Crestanello; Mohamad Alkhouli
Journal:  J Am Heart Assoc       Date:  2021-01-05       Impact factor: 5.501

5.  A new technique for tricuspid valve repair addressing the subvalvular apparatus in functional tricuspid regurgitation.

Authors:  Torsten Doenst; Gloria Faerber
Journal:  Interact Cardiovasc Thorac Surg       Date:  2021-10-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.